Odyssean »

Ambarella shares owned by Odyssean

Quarter-by-quarter ownership of Ambarella (AMBA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Ambarella

Tip: Access up to 7 years of quarterly data

All positions including Ambarella held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambarella by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 26k 85.80

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Ambarella

BlackRock
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Millennium Management
Manufacturers Life Insurance Company
Legal & General Group
Geode Capital Management
T. Rowe Price Associates
Morgan Stanley
Stephens Investment Management Group
Dimensional Fund Advisors
Connor, Clark & Lunn Investment Management
Exchange Traded Concepts
Jane Street

View all funds holding Ambarella